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ABSTRACT
Objective: Hyperuricemia involves an increase in serum uric acid levels, resulting in kidney damage, increased mortality, and reduced quality of life. 
Inhibitors of xanthine oxidase, which catalyzes the last step in uric acid synthesis, are targets for therapeutic intervention.
Methods: An ethnopharmacological approach, screening four native Indonesian herbal medicinal plants with reported activity against hyperuricemia, 
was used for preliminary studies, fractionating methanolic extracts by solvent partitioning. Fractions were then tested in vitro for xanthine oxidase 
inhibitory activity, and the most active fraction was then subjected to preliminary phytochemical screening.
Results: The target tissue of the four herbal medicinal plants investigated was Indian bay leaf (Syzygium polyanthum Wight.), God’s crown fruit 
(Phaleria macrocarpa Boerl.), snake fruit peel (Salacca edulis Reinw.), and Job’s tears tuber (Cyperus rotundus Linn.). Each sample was extracted by 
maceration with 80% methanol. The concentrated extract was then fractionated by the liquid-liquid partition method (1:1 v/v) using n-hexane, ethyl 
acetate, butanol, and methanol sequentially as solvents. The results revealed that the ethyl acetate fraction was the most active fraction. S. polyanthum 
leaf and C. rotundus tuber showed the greatest potential in inhibiting xanthine oxidase, with half-maximal inhibitory concentrations of 18.43 and 
10.50 μg/ml, respectively. Enzyme kinetics analysis shows that each plant fraction works as a competitive inhibitor of xanthine oxidase.
Conclusion: Preliminary screening identified the ethyl acetate fractions of two native Indonesian herbal medicinal plants as showing potential for 
anti-hyperuricemia activity.
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INTRODUCTION
Hyperuricemia is a pathological condition where uric acid levels in the 
blood are elevated above the normal range [1]. This condition can persist 
for a long time without any symptoms. During the asymptomatic period, 
the deposition of uric acid crystals may lead to chronic pain, causing 
joint damage in some patients [2]. In young patients, hyperuricemia 
stimulates oxidative stress, inflammation, and inflammatory response 
as feedback from the oxidative stress triggered by the high uric acid 
concentration itself [3]. Acute and chronic inflammation due to crystal 
deposition in joints and soft tissues is a consequence that occurs when 
hyperuricemia is not immediately treated [4].
Uric acid is the final product of the catabolism of purine nucleotides. 
There are two main sources of purines. The first one is endogenous, 
originating from the synthesis of purines de novo and their subsequent 
breakdown as part of nucleic acid turnover. Purines can also come 
from exogenous sources, such as food [5]. Many enzymes are involved 
in the purine catabolism pathway, where eventually adenine will 
be converted into hypoxanthine and guanine will be converted to 
xanthine. Hypoxanthine will be oxidized to xanthine, and finally, 
xanthine is oxidized again by xanthine oxidase to form uric acid [1]. 
Xanthine oxidase inhibitors, such as purine analogs, are used to treat 
hyperuricemia and gout, and there is pharmaceutical interest in 
the exploitation of natural plant xanthine oxidase inhibitors such as 
inositols and flavonoids.
An ethnopharmacological approach investigates the basis of the 
traditional use by native people of natural materials, such as plants, 
animals, fungi, microorganisms, and minerals, in treating specific 
medical conditions [6]. Many modern pharmaceuticals originated 
from traditional medicine and ethnopharmacology [7], either directly, 
using natural compounds as drugs, or as lead compounds in drug 
development.
Tubers of rumput teki or Job’s tears (Cyperus rotundus Linn.) have been 
widely used in Indonesia as a traditional medicine to treat dysentery 
and painful joints, and as a diuretic [8], whereas leaves of the Indian 
bay leaf (Syzygium polyanthum Wight.) are used as a traditional 
medicine to treat muscle pain and uric acid accumulation [9]; a water 
extract of S. polyanthum has also been reported to significantly reduce 
blood plasma uric acid concentrations [10]. God’s crown (Phaleria 
macrocarpa Berl.) is a native plant from Papua, Indonesia, the fruit 
of which has been used traditionally for a number of medicinal uses, 
including the treatment of kidney disease [11]. Snake fruit (Salacca 
edulis Reinw.) peel is traditionally used to reduce uric acid levels 
and has been shown to reduce uric acid levels in the Wistar rat 
model [12]. The aim of the current study was to investigate the potential 
of these ethnopharmacological plants to reduce uric acid levels through 
inhibition of the xanthine oxidase pathway.
MATERIALS AND METHODS
Plant material
Indian bay leaf (S. polyanthum) and God’s crown fruit (P. macrocarpa) 
were obtained from a local market in West Java, Indonesia. Fruit of 
snake fruit (S. edulis) was obtained from Magelang, Indonesia and 
tubers of Job’s tears (C. rotundus) were obtained from Bogor, Indonesia. 
Each of the samples was authenticated by Herbarium Bogoriense. The 
samples were cleaned, impurities were removed, and each sample was 
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then dried at 60°C. The dried samples were powdered and stored in 
desiccator cabinets at room temperature until further analysis.
Preparation of extract
The preparation of extract was performed based on Yanti et al. with a 
number of modifications [13]. Each sample powder (1 kg) was extracted 
using the maceration method with 80% (v/v) methanol as the solvent. 
The powder was allowed to extract in the methanol for approximately 
24 h, before being filtered. The solid was re-extracted 3 more times, and 
the filtrates obtained were combined and the pooled filtrate was then 
evaporated to dryness using a rotary vacuum evaporator at 40°C. This 
crude extract was stored at −20°C before use for further analysis.
Procedure of fractionation
The extract obtained was dissolved in 200 ml dH2O, and then fractionated 
by liquid-liquid partitioning (1:1 v/v), using a sequence of solvents, from 
non-polar to polar, namely, n-hexane, ethyl acetate, butanol, and methanol. 
Partitioning was carried out 3 times in a separating funnel, each for 1 h. 
The fractions from one extract were combined and dried with a rotary 
vacuum evaporator to produce a concentrated extract fraction [14].
Determination of xanthine oxidase inhibitory activity
The determination of xanthine oxidase inhibitory activity was 
performed based on Ahmad et al. with a number of modifications [15]. 
A sub-sample (10 mg) of an extract or extract fraction was dissolved 
in 4 gtt of dimethyl sulfoxide (DMSO), before adding CO2-free dH2O to 
obtain a 1.0 μg/ml stock solution. The stock solution was then diluted 
to a 0.1 μg/mL working solution. One milliliter of working solution was 
added to 2.9 ml 0.05 M phosphate buffer pH 7.5, 2 ml 0.2 mM xanthine, 
and 1 ml of 1N HCl, the reaction mixture then being shaken vigorously 
until homogeneous. The mixture was incubated for 10 min at 25°C, 
before adding 0.1 ml 0.1 unit/ml xanthine oxidase and 1 ml 2N HCl. 
The final mixture was incubated at 25°C for 30 min and absorbance 
(A290) was measured after the incubation was terminated. The control 
used DMSO without the extract or fraction sub-sample. The percentage 
inhibition was calculated from the equation below:
Sample absorbanceInhibition(%)=1 - ×100
Control absorbance
Extracts or fractions that achieved an inhibitory effect of more than 
50% were tested again using the same method at concentrations of 
5, 10, 20, 40, or 80 μg/mL to determine the half-maximal inhibitory 
concentration (IC50) value by regression.
Preliminary phytochemical screening
In this study, preliminary phytochemical screening was carried out 
to determine the presence/absence of phytochemicals of a particular 
group in the extract fractions that had the greatest inhibitory activity 
against xanthine oxidase. Phytochemical screening was performed for 
a number of chemical groups, namely, alkaloids, glycosides, saponins, 
flavonoids, tannins, and terpenes.
Identification of alkaloids
A sample (500 mg) of extract fraction was dissolved in 10 ml of 0.2 N 
aqueous HCl, then heated for 2 min. The mixture was filtered, and the 
filtrate was used as the test solution (TS). Each 1 ml aliquot of TS 
was reacted with 2 ml of various test reagents. Bouchardat’s reagent 
resulted in a dark-brown precipitate in the presence of alkaloids, 
whereas Mayer’s reagent resulted in a white precipitate for a positive 
reaction, and Dragendorff’s test showed a reddish-orange precipitate 
as a positive result [16].
Identification of glycosides
A sample (300 mg) was dissolved in 15 ml of 10% HCl, then filtered. The 
filtrate obtained was washed with ether 3 times, and the resulting filtrate 
was evaporated to dryness at 40°C. To the filtrate were then added 2 ml 
methanol, this solution being used as the TS. An aliquot (1 ml) of TS was 
evaporated to dryness and dissolved in 20 ml concentrated acetic acid 
and 1 ml concentrated sulfuric acid. A green or blue color indicated the 
presence of glycosides. Identification with Molisch’s test was performed 
by dissolving the evaporated TS in 2 ml dH2O and 5 ml Molisch’s reagent. 
To the solution, 2 ml sulfuric acid was added carefully. The formation 
of a reddish-purple colored ring at the junction between the two layers 
indicated the presence of glycosides [17].
Identification of saponins
The identification of saponin compounds was carried out by the simple 
froth test method. A sample (500 mg) of the extract fraction was put in 
a test tube, to which was added 10 ml of hot distilled water, and the tube 
was shaken vigorously for 10 s. The formation of foam that lasted for at 
least 10 min and that did not disappear with the addition of 1 ml of 2N 
HCl, indicated the presence of saponin compounds [17].
Identification of flavonoids
Flavonoid identification was performed using Shinoda test methods. 
A sample (500 mg) of the fraction was dissolved in 2 ml of ethanol, 
to which was added 500 mg of Zn powder and 2 ml 2N HCl, following 
which the reaction mixture was allowed to stand for 1 min. Following 
the addition of 10 ml concentrated HCl, the appearance of a red color 
after 2–5 min incubation indicated the presence of flavonoids. The 
same method was used with 100 mg of Mg powder replacing the Zn 
powder to identify the presence of flavones, chalcones, and aurones. 
The appearance of a yellow to orange color indicated the presence of 
compounds of flavones, chalcones, or aurones [16].
Identification of tannins
A sample (200 mg) of the fraction was dissolved in 5 ml of hot distilled 
water, to which was added 10% NaCl, and the solution was filtered. The 
filtrate (TS) was then tested using the gelatin test and FeCl3 test methods. 
To 1 ml of TS was added 3 ml 10% gelatin solution, with the formation of 
a white precipitate, indicating the presence of tannins. The ferric chloride 
test was performed by added 2 ml 3% FeCl3 to 1 ml of TS, with a change in 
coloration to violet-green indicating that the sample contained tannins [17].
Identification of terpenes
A sample (200 mg) of the fraction was dissolved in a solution of 
concentrated acetic acid:concentrated sulfuric acid (2:1 v/v), at which 
point the formation of a greenish-red or violet-blue color indicated the 
presence of terpenes. To confirm the result, the procedure continued 
by spraying a sample with a solution of p-anisaldehyde in concentrated 
sulfuric acid, when dark-blue, green, red, or brown fluorescence at 
366 nm ultraviolet light indicated the presence of terpenes [17].
RESULTS AND DISCUSSION
Xanthine oxidase inhibitory activity
The data obtained showed that the ethyl acetate fraction from each 
sample showed the highest inhibitory activity against xanthine 
Fig. 1: Xanthine oxidase inhibitory activity from solvent 
partitioning fractions of a methanolic extract of S. polyanthum, 
C. rotundus, S. edulis, and P. macrocarpa. Each sample is expressed 
as the mean±standard error of the mean of two independent 
experiments
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oxidase, in a comparison with the other extract fractions (Fig. 1). 
The ethyl acetate fraction of all four plant crude extracts had the 
highest mean±standard error of the mean inhibitory activity, 
namely, S. polyanthum (52.54 ± 1.29%), C. rotundus (51.01 ± 0.95%), 
P. macrocarpa (50.00±1.16%), and S. edulis (35.58±2.00%). Interestingly, 
S. polyanthum exhibited the highest xanthine oxidase inhibitory activity 
in each of the solvent fractions (Fig. 1). Fractions that exhibited a 
xanthine oxidase inhibitory effect of greater than 50% could have 
their IC50 value determined; this was not possible for S. edulis. Analysis 
showed that S. polyanthum had a IC50 of 18.43 μg/ml, C. rotundus 
10.50 µg/ml, and P. macrocarpa 19.23 µg/ml, whereas allopurinol, a 
well-known inhibitor of xanthine oxidase activity exhibited a IC50 of 
0.067 μg/ml, making it more than 100 times more active than the most 
active plant extract, C. rotundus.
To investigate the kinetics of the xanthine oxidase inhibition by the 
plant fractions, we also performed the Lineweaver–Burk plot. The 
results showed the intersection of the straight line from the test with 
and without the inhibitor at the Y-axis. This is interpreted as all four 
plant fractions operating a competitive inhibition mechanism against 
xanthine oxidase. In such a system, there is no change in the Vmax value, 
but there is a change in the value of Km that needs a higher substrate 
concentration to reach the Km value [18]. The difference between 
reversible and irreversible inhibition is that reversible inhibitors are 
easier to dissociate, thus causing shorter inhibition time. Competitive 
inhibition allows both the inhibitors and the substrates to bind to 
the same active site of the enzyme, but they cannot occupy the same 
active site of the enzyme at the same time. Therefore, the inhibitors will 
compete with the substrate to occupy the active site of the enzyme [19]. 
Basically, xanthine oxidase is an enzyme with low specificity. Because 
xanthine oxidase participates in the catabolism of xenobiotics, such as 
antiblastic and antimetabolic drugs, a xanthine oxidase inhibitor should 
be used carefully when these drugs are also being taken [20].
Phytochemical screening
The most active fraction (the ethyl acetate fraction) of each sample 
extract in terms of xanthine oxidase inhibitory activity was subjected 
to phytochemical screening to reveal which groups of phytochemical 
compounds were present. As shown in Table 1, all of the ethyl acetate 
fractions from the original crude methanolic extract of the four medicinal 
plants studied contained glycosides and flavonoid compounds.
The S. polyanthum ethyl acetate fraction of the leaf extract contained 
all of the compounds tested for, namely flavonoids, terpenes, alkaloids, 
saponins, tannins, and glycosides (Table 1). Recent work showed a 
number of bioactive compounds in the ethyl acetate fraction of the 
S. polyanthum leaf methanolic extract, including α-pinene, linalool, 
nerolidol, caryophyllene oxide, farnesol, phytol, squalene, β-tocopherol, 
α-tocopherol, β-sitosterol, α-humulene, neophytadiene, hentriacontane, 
and octanal [21].
The Abd Rahim et al. study [21] also reported that the ethyl acetate 
fraction of the C. rotundus tuber methanolic extract contained glycoside 
compounds, which were suspected to be the terpenoid iridoid glycoside 
groups such as 1α-meth-oxy-3β-hydroxy-4α-(3′,4′-dihydroxyphenyl)-
1,2,3,4,-tetra-hydronaphthalin and 1α,3β-dihydroxy-4α-(3′,4′-
dihydrox-yphenyl)-1,2,3,4,-tetrahydronaphthalin or other rotundus 
side compounds and their isomers that had been reported by another 
research team [22], although this tentative identification requires 
confirmation. The presence of flavonoid compounds in the C. rotundus 
fraction, which we identified, was also reported by Kilani et al. [23]. 
They described that the ethyl acetate fraction of C. rotundus contained 
flavonoid compounds such as afzelechin, catechin, quercetin, and 
luteolin.
We reported that the ethyl acetate fraction of S. edulis contained a 
number of phytochemical constituents such as glycosides, flavonoids, 
and tannins (Table 1). Afrianti et al. discovered that the ethyl acetate 
fraction of S. edulis contained a number of phytochemical compounds 
such as 3-hydroxystigmastan-5(6)-en and pyrolle-2,4-dicarboxylic acid, 
methyl ester [24], whereas another phytochemical screening study also 
reported that S. edulis contained flavonoids and tannins [24,25]. The 
positive results for glycosides detected in this current research are 
expected to be associated with the high sugar content in S. edulis.
Based on Table 1, the phytochemical compounds present in the 
ethyl acetate fraction of P. macrocarpa include glycosides, saponins, 
flavonoids, tannins, and terpenes. These data are similar to those in an 
article reviewing data reported by Alara et al. The positive results for 
glycosides, saponins, and terpenes could have been due to the presence 
of fevicordin in P. macrocarpa, which is classified as terpenoid. In the 
form of sugar conjugates, fevicordin would give positive results for 
glycoside as well as saponin. It was also reported that P. macrocarpa 
contains flavonoids, tannins, and gallic acid [26].
CONCLUSION
Various plants used in ethnomedicine have been scientifically proven to 
have beneficial effects in treating hyperuricemia through a competitive 
inhibitory mechanism against xanthine oxidase. In the current study, 
C. rotundus tuber was the herbal medicinal plant with the greatest 
potential for development as a hyperuricemia treatment by inhibiting 
xanthine oxidase (IC50=1 0.50 µg/ml).
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